🇺🇸 FDA
Pipeline program

Mipomersen sodium

301012-CS12

Phase 3 small_molecule completed

Quick answer

Mipomersen sodium for Hypercholesterolemia is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Hypercholesterolemia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials